By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today reported that its first-quarter revenues inched up around 1 percent, while its net loss jumped 67 percent.

The Princeton, NJ-based firm had total revenues of $14.1 million for the three-month period ended March 31, compared to $14 million in revenues for the first quarter of 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.